And Other Rising Companies – a Market Report Assessing Developers and Producers of Competitor Biologics
Report Details Who Are the Leaders in the Emerging Biosimilar Drugs Market? Visiongain’s New Analysis Gives Company Assessments, Discussions and Predictions Where are companies in the Biosimilar market heading? If you are involved in this sector you must read this brand new report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead Our 233-page report provides 126 tables, charts, and graphs, giving a clear view on companies in the biosimilar market. Who are the most important and promising biosimilar drug companies? And what are their sales potentials? Discover this information in our updated report, which analyses 25 leading developers, producers and marketers of biosimilars. The report also covers other firms, including big pharma companies entering that industry.
Molecules giving rise to biosimilars – explore where progress occurs Our report discusses biosimilar competition for these five therapeutic agents – products and research and development: • Adalimumab • Infliximab • Etanercept • Darbepoetin alpha • Rituximab.
In particular, our report analyses 25 leading biosimilar specialists worldwide. First of all, Chapter 4 gives profiles of leading biosimilar companies based in the US, Western Europe and Israel: • Hospira (Pfizer) • Mylan • Sandoz (Novartis) • STADA Arzneimittel • Teva Pharmaceutical Industries
Chapter 5 profiles leading companies in China: • 3SBio • Beijing ShuangLu Pharmaceutical Co. • Qilu Pharmaceutical • Shanghai Fosun Pharmaceutical Group • Tonghua Dongbao Pharmaceutical Co.
Chapter 6 profiles leading companies in India: • Biocon • Dr. Reddy’s Laboratories • Intas Biopharmaceuticals • Ranbaxy (Sun Pharma) • Reliance Life Sciences • Wockhardt • Zydus Cadila
Chapter 7 profiles leading companies in Latin America: • Amega Biotech • Biosidus • Probiomed
Chapter 8 profiles leading companies in the rest of the world: • Biocad • Bioton • Celltrion • Dong-A • LG Life Sciences
Our report also reviews 25 other companies rising in importance. See what is possible from 2017, discovering what leading companies do and their commercial outlooks.
With our report, you will see who and what shapes the biosimilars industry, including policies, regulatory concerns and other forces influencing those companies and their market, affecting its revenues and profits. Discover what the future holds for leading organisations.
How the 25 Top Biosimilar Drug Manufacturers report helps you In summary, our 233-page report provides you with the following knowledge: • Profiles of 25 leading biosimilar companies and other relevant firms – assess products, results, strategies, technologies and outlooks, also gaining company level revenue forecasting for five leading producers’ biosimilar drug sales • R&D for biosimilars – see activities by company, finding what goes on in that industry, investigating its technological and commercial potentials • Competition and opportunities – explore what affects the biosimilars market, finding what shapes its future, especially prospects for developing business
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Our reports have been used by over 10K customers, including:
111 pages •
By Infiniti Research Limited
• Dec 2018
About this market Patients and physician’s willingness to switch to biosimilars is expected to drive growth in the market. Majority of physicians, especially rheumatologists, preferred to prescribe a bio-originator instead of biosimilar as the first line therapy for the treatment. However, the physician and patients...
Post Menopausal Osteoporosis - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Post Menopausal Osteoporosis - Pipeline Review, H2 2018, provides an overview of the Post Menopausal Osteoporosis (Metabolic Disorders) pipeline landscape. Postmenopausal...
Women Infertility - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Women Infertility - Pipeline Review, H2 2018, provides an overview of the Women Infertility (Women’s Health) pipeline landscape. Infertility refers to failure...
Asthma - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Asthma - Pipeline Review, H2 2018, provides an overview of the Asthma (Respiratory) pipeline landscape. Asthma is a chronic disease involving the airways in the lungs....
Bone Metastasis - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Bone Metastasis - Pipeline Review, H2 2018, provides an overview of the Bone Metastasis (Oncology) pipeline landscape. Bone metastasis occurs when cancer cells...
The Global Biosimilars Partnering Terms and Agreements 2010 to 2018 report provides an understanding and access to the Biosimilars partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Biosimilars partnering deals Disclosed headlines, upfronts, milestones and royalties...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.